Paediatrics

From Development to Commercialisation

With a wealth of experience in paediatric medication, we understand the unique challenges faced in developing, manufacturing and packaging treatment specifically tailored for young patients. Offering comprehensive solutions which ensure the safety, efficacy, and appropriate dosing of medications for children. We recognise that paediatric patients span a wide age range, from newborn to adolescents and all have unique needs and requirements.

https://vimeo.com/835701549

Development

Almac’s formulation development scientists specialise in creating age appropriate and palatable drug formulations. Considering factors such as taste, texture, dosage forms and, ease of administration, we develop formulations that are both effective and well-tolerated by paediatric patients. We understand and adhere to all regulatory guidelines to ensure that our product meets the highest standard of quality and safety standard.

Manufacturing

Our manufacturing facilities are equipped with cutting-edge technology to produce the highest quality medications for paediatric patients. Our manufacturing capabilities include:

Dispensing
Blending
Dry granulation
Wet granulation / fluid bed processing
Automated (mini) tablet compression
Mini tablet coating
Mini tablet encapsulation

Mini tablets
Powders / granules
Liquids
Orodispersible

Stick-packing
Sachet filling
Powder in bottle filling
Liquid in bottle
Liquid in capsules

Packaging

Almac’s comprehensive range of paediatric packaging options ensures safety, convenience, and adherence to regulatory standards for children’s medications. Our packaging facilities are equipped with high-level technology to provide the highest quality packaging. Our capabilities include:

A member of the European Paediatric Formulation Initiative (EUPFI)

As a member of the EUPFI, Almac Pharma Services’ can contribute to improving access to paediatric medicines by sharing their expertise in this field and collaborating with other industry, academic and regulatory expert partners to identify innovative solutions to the challenges associated with developing medicines for children. By aligning with EuPFI’s mission, Almac continues its contribution to improving paediatric healthcare worldwide.

Single Provider Advantage

Providing development, manufacture and commercial services from a single source ensures that the formulation and processing knowledge gained throughout the development phase is effectively transferred to ongoing commercial supply for a seamless experience.

Our experienced teams have successfully delivered multiple Paediatric formulations to development and commercialisation from our custom-built facilities.

Contact us